Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Olgac

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ISA Transactions|January 1, 1976
Optimal control of artificial aeration in river networksN M Olgac, R W Longman, C A Cooper
Allergy|July 16, 2015
Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classificationS Demir, M Olgac, D Unal, et al.
Journal of Investigational Allergology & Clinical Immunology|March 26, 2016
Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity ReactionS Demir, M Olgac, S Saglam, et al.
Allergy|March 23, 2016
ASA must be given to classify multiple NSAID-hypersensitivity patients as selective or cross-intolerantN Blanca-López, G Bogas, I Doña, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ISA Transactions|January 1, 1976
Optimal control of artificial aeration in river networksN M Olgac, R W Longman, C A Cooper
Allergy|July 16, 2015
Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classificationS Demir, M Olgac, D Unal, et al.
Journal of Investigational Allergology & Clinical Immunology|March 26, 2016
Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity ReactionS Demir, M Olgac, S Saglam, et al.
Allergy|March 23, 2016
ASA must be given to classify multiple NSAID-hypersensitivity patients as selective or cross-intolerantN Blanca-López, G Bogas, I Doña, et al.
Pageof 1